Phenotype measures set

ID, description, units MPD:36127   aspartate transaminase (serum AST), treated group   [IU/L]
trichloroethylene study
Measures • treated group:    • 2h    • 8h    • 24h
Data set, strains Rusyn2   inbred   15 strains     sex: m     age: 7wks
Procedure metabolic panel
Comparisontimecourse but different cohorts
Ontology mappings



Dimensions Width:  ×  Height: px
Values
Graph Type
Plot Options
Download Plot   

Rusyn2 - aspartate transaminase (serum AST), treated group

Female

Male



  RM-ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
time 2 1352.5587 676.2793 0.0539 0.9475
strain 14 250492.3372 17892.3098 1.4271 0.1574
time:strain 28 431746.4972 15419.5178 1.2299 0.2305
Residuals 89 1115836.6667 12537.4906

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelNo.
strains
SexAge
Rusyn2 36127 metabolic panel trichloroethylene aspartate transaminase (serum AST), treated group   [IU/L]   2h after treatment   AST_2_tce inbred 15 m 7wks
Rusyn2 36128 metabolic panel trichloroethylene aspartate transaminase (serum AST), treated group   [IU/L]   8h after treatment   AST_8_tce inbred 15 m 7wks
Rusyn2 36129 metabolic panel trichloroethylene aspartate transaminase (serum AST), treated group   [IU/L]   24h after treatment   AST_24_tce inbred 15 m 7wks